Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under CytomX Therapeutics, Inc. in our court records and SEC 8-K records (as of 2026-10-18).
- Leadership changes: the latest reported is Charles Fuchs, Director (Form 8-K filed 2026-07-27). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Kynam Capital Management, LP (filed 2026-08-14).
Who is behind it
CytomX Therapeutics, Inc.: incorporated in Delaware; business address in South San Francisco, California; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-08-14).
Officers and directors, each with the role and the filing that names them:
- Sean McCarthy: Executive Officer, Director (Form D, 2023-08-17)
- Marcia Belvin: Executive Officer (Form D, 2023-08-17)
- Jeff Landau: Executive Officer (Form D, 2023-08-17)
- Chris Ogden: Executive Officer (Form D, 2023-08-17)
- Lloyd Rowland: Executive Officer (Form D, 2023-08-17)
- Alan Ashworth: Director (Form D, 2023-08-17)
- Halley Gilbert: Director (Form D, 2023-08-17)
- Elaine Jones: Director (Form D, 2023-08-17)
- James Meyers: Director (Form D, 2023-08-17)
- Mani Mohindru: Director (Form D, 2023-08-17)
- Matthew Young: Director (Form D, 2023-08-17)
- Wayne Chu: Executive Officer (Form D, 2023-08-17)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-08-14 | Kynam Capital Management, LP | 9.96% |
| Schedule 13G/A, 2026-08-14 | Point72 Asset Management, L.P. | 3.6% |
| Schedule 13G, 2026-08-07 | State Street Corporation | 5.4% |
| Schedule 13G, 2026-08-03 | Bank Of America Corp /De/ | 7% |
| Schedule 13G, 2026-07-27 | Blackrock, Inc. | 7.6% |
| Schedule 13G/A, 2026-05-15 | Kynam Capital Management, LP | 6.9% |
| Schedule 13G/A, 2026-05-15 | Perceptive Advisors LLC | 4.6% |
| Schedule 13G/A, 2026-05-15 | Venrock Healthcare Capital Partners Iii, L.P. | 4.6% |
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-07-27 | Charles Fuchs | Director | appointed |
Money raised
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2023-08-17 | $30M | $30M |
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
Permanent URL:
https://mentionfox.com/who-owns/cytomx-therapeuticsLast updated 2026-10-18
Who owns CytomX Therapeutics, Inc.? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/cytomx-therapeutics